CORTECH INC
DFAN14A, 1998-08-26
PHARMACEUTICAL PREPARATIONS
Previous: CIRCUS CIRCUS ENTERPRISES INC, S-3/A, 1998-08-26
Next: CORTECH INC, DEFA14A, 1998-08-26




                 

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                            SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
                                (Amendment No. )

Filed by the Registrant |_|
Filed by a Party other than the Registrant |X|

Check the appropriate box:

|_| Preliminary Proxy Statement
|_| Definitive Proxy Statement
|X| Definitive Additional Materials
|_| Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12


                                 Cortech, Inc.
- --------------------------------------------------------------------------------
                (Name of Registrant as Specified In Its Charter)

                      Asset Value Fund Limited Partnership
- --------------------------------------------------------------------------------
                   (Name of Person(s) Filing Proxy Statement)

Payment of Filing Fee (Check the appropriate box):

|_| $125 per Exchange Act Rule 0-11(c)(1)(ii), 14a-6(i)(1) or 14a-6(j)(2).
|_| $500 per each party to the controversy pursuant to
    Exchange Act Rule 14a-6(i)(3).
|_| Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
|X| No fee required

1) Title of each class of securities to which transaction applies:

   Common Stock
   -----------------------------------------------------------------------------

2) Aggregate number of securities to which transaction applies:

   -----------------------------------------------------------------------------

3) Per unit price or other underlying value of transaction computed
   pursuant to Exchange Act Rule 0-11:*

   -----------------------------------------------------------------------------

4) Proposed maximum aggregate value of transaction:

   -----------------------------------------------------------------------------

|_| Check box if any part of the fee is offset as provided by
    Exchange Act Rule 0-11(a)(2) and identify the filing for which
    the offsetting fee was paid previously.  Identify the previous
    filing by registration statement number, or the form or schedule
    and the date of its filing.

    1) Amount previously paid:
                               -------------------------------------------------
    2) Form, Schedule or Registration No.
                                         ---------------------------------------

    3) Filing party:
                    ------------------------------------------------------------

    4) Date filed:
                    ------------------------------------------------------------

___________
*Set forth the amount on which the filing fee is calculated and state how it was
 determined.

(032796DTI)

<PAGE>

<TABLE>
<CAPTION>


Vol. 1 No. 3                                                                                                        August 28, 1998
- -----------------------------------------------------------------------------------------------------------------------------------
                                                          THE ASSET VALUE
                                                               NEWS
                                                   All the News You Need to Vote
- -----------------------------------------------------------------------------------------------------------------------------------
     
                                                   FINGERHUT FORECASTS THE FUTURE:
                                                             MORE LOSSES!

<S>                                          <C>                                             <C>
Fingerhut Plan:  Lose More                   Yada, Yada, Yada                                SCIENCE AND MAKING MONEY          
Money; 3,000,000 More Reasons                                                                IS NOT AN OXYMORON
to Vote For Asset Value                      Fingerhut rambles on and on about the
                                             value of Cortech's technology, in our           Management has not denied that Pure
Last year, management said its               view, to avoid the real issue which is          World, operated by the Koethers, is a
downsizing would reduce Cortech's            his record of mismanagement.                    science based company which is
annual losses below $1,000,000.                                                              making lots of money for its
Losses this year annualized are 5            In this contest you are not voting for or       stockholders.  A dollar invested in
times management's prediction.  Now          against the Cortech technology.  We are         Pure World five years ago would now
Fingerhut says that he has a new, in         the largest stockholders of Cortech.            be worth over $6.  By comparison,
his words, "viable and prudent" plan,        Why would we throw away potential               that same dollar invested in Cortech
to deliver value.  If the past becomes       value for its science?                          is now worth less than $0.03.  The
the future, the only thing we believe                                                        Koethers with Pure World have 
you can be sure of is that Fingerhut         In our view, Fingerhut's claims about           demonstrated that science and making
will deliver more losses.  In his case,      the imminent value of the Cortech               money need not be an oxymoron.
words speak as loud as actions.  Even        technology flies in the face of repre-                    FOR ONCE WE AGREE
he admits that his new plan at best          sentations made to the stockholders             Management says it now all comes
calls for more cash losses of                when he pushed for the BioStar deal             down to one question:
$2,000,000 to $3,000,000 over two            only last February.  If Fingerhut                 Who do you want to lead your
years reducing cash to only $9               believed that this technology would be          company?
million.  Is this what he calls prudent      realized within two years, for an               We think the answer is clear.
and viable?                                  additional $2,000,000 to $3,000,000               Vote for Asset Value's Nominees!
  Time and Money are Running Out             then why was he willing to sell out to          Asset Value's nominees, as 
Fingerhut has lost over $87,000,000          BioStar so cheap?                               management itself agrees, have
on his plans to develop Cortech's            WE ASK MR. FINGERHUT:                           diverse experience, a finance
technology.  As he points out "Along         WHICH IS TRUE?                                  professor; a C.P.A.; a natural products
the way, three major pharmaceutical          WHAT YOU SAID THEN OR                           executive; and yes even Mark Jaindl,
companies put up their money in              WHAT YOU SAY NOW?                               a bank president, whose family owns 
support of our ideas and plans."                                                             one of America's largest integrated
Precisely!  And where are these three        ----------------------------------              turkey enterprises.  You can make fun
companies now, Mr. Fingerhut?                                                                of Mark Jaindl, Mr. Fingerhut, but at
- -------------------------------                                                              least he knows a turkey when he sees
CONTENTS:                                    VOTE FOR CHANGE                                 one.
Fingerhut Plan:  Lose More                                                 
  Money ......................1              VOTE FOR ASSET VALUE                            --------------------------------------
Science and Making Money is
  Not an Oxymoron.............1              VOTE THE GREEN BALLOT                           VOTE THE GREEN BALLOT


</TABLE>



<PAGE>

                              TIME IS RUNNING OUT!

                      A PICTURE IS WORTH A THOUSAND WORDS
                      -----------------------------------

                                 COMPARISON OF
                CORTECH'S STOCK PERFORMANCE (NASDAQ SYMBOL-CRTQ)
                                       TO
                  THE NASDAQ BIOTECHNOLOGY INDEX (IXBT) AND THE
                AMERICAN STOCK EXCHANGE BIOTECHNOLOGY INDEX (BTK)
                              

                                [GRAPH THE ABOVE]

<TABLE>
<CAPTION>

               Cortech         IXBT        BTK
               ------          -----      ------
<S>           <C>             <C>         <C>   
1993          $18.25          197.88      115.78

1994           14.25          161.40       82.06

1995            3.65625       304.30      133.77

1996            3.8125        314.48      144.56

1997            2.03125       304.89      163.28

7/17/1998        .50          335.15      144.16

</TABLE>
                             NOT A PRETTY PICTURE!



                                  SAVE CORTECH

                         SEND IN THE GREEN PROXY BALLOT

                         VOTE YES TO INCREASE THE BOARD

                    VOTE FOR ALL OF ASSET VALUE'S NOMINEES!


                                    IMPORTANT

     If your shares are held in "Street  Name" only your bank or broker can vote
your shares, and only upon receipt of your specific instructions. Please contact
the person  responsible  for your account and  instruct  them to execute a GREEN
PROXY BALLOT as soon as possible.

     If you have any questions or need further assistance in voting, please call
John W. Galuchie,  Jr., of Asset Value Fund Limited Partnership collect at (908)
234-1881, or our proxy solicitor:

                           BEACON HILL PARTNERS, INC.
                                 90 BROAD STREET
                            NEW YORK, NEW YORK 10004
                                 (800) 253-3814





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission